Pan-Asian adaptation of the 2024 ESMO guidelines for renal cell carcinoma: consensus of experts from ten Asian oncology societies on diagnosis, treatment and follow-up, voted on evidence independent of local drug access, which is discussed separately.
Guideline
Kanesvaran et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma